Jessie Modlin, PharmD, BCOP

home / authors / jessie-modlin-pharmd-bcop

Articles

Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com

Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors

Richa Shah, PharmD, BCOP;Jessie Modlin, PharmD, BCOP;Rezarta Lako, PharmD, BCPS;Yuxi Lei, PharmD;Adina Kagan, PharmD Candidate;Cradesha Perry, PharmD, MBA;Luisa Giannangelo, MBA, RPh;Rebecca Pokorny, PharmD, BCPS, BCOP;Kevin Pang, PharmD
August 19th 2024

This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.

Read More

CLL in blood -- Image credit: Dr_Microbe | stock.adobe.com

Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia

Richa Shah, PharmD, BCOP;Rebecca Pokorny, PharmD, BCPS, BCOP;Luisa Giannangelo, MBA, RPh;Cradesha Perry, PharmD, MBA;Adina Kagan, PharmD Candidate;Yuxi Lei, PharmD;Rezarta Lako, PharmD, BCPS;Jessie Modlin, PharmD, BCOP;Kevin Pang, PharmD
June 14th 2024

This article provides an overview of data supporting the utility of covalent Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia and details important considerations when choosing among agents.

Read More

Lymphoma diagnosis -- Image credit: tashatuvango | stock.adobe.com

Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma

Valassia Antigone "Noni" Theocharides, PharmD Candidate;Luisa Giannangelo, MBA, RPh;Jessie Modlin, PharmD, BCOP;Tesnim Shash, PharmD Candidate;Sukeina Nasser, PharmD, CPh, PACS
February 23rd 2024

Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.

Read More

Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical Practice

Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical Practice

Jessie Modlin, PharmD, BCOP;Khanh Huynh, PharmD, BCACP, APh;Kevin Pang, PharmD;Whitney Fakolade, PharmD, RPh
June 9th 2023

Systemic treatment options have historically been limited to traditional chemotherapy agents.

Read More

Latest Updated Articles

Sweden - March 23, 2015: McDonald's yellow and red logo advertising sign placed on a pole with against clear blue sky
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Gabapentin Differs From Pregabalin in Several Key Ways
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
The US Capitol building.
Published: August 30th 2024 | Updated: November 21st 2024
Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report
In this photo illustration, the Centers for Medicare and Medicaid Services (CMS) logo is displayed on a smartphone screen.
Published: October 8th 2024 | Updated: November 21st 2024
What Drug Rates Are Reported in Price Transparency Data?
Image Credit: Syda Productions - stock.adobe.com
Published: October 7th 2024 | Updated: November 21st 2024
What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars